Zusammenfassung
BackgroundRituximab plus combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is broadly accepted as standard for the treatment of diffuse large B-cell lymphoma (DLBCL). Nevertheless, there is sparsely data concerning the management of elderly patients.MethodsWe performed a retrospective study of treatment with rituximab and low-dose trofosfamide in ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric